BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28716934)

  • 21. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.
    Carcolé M; Kummer S; Gonçalves L; Zamanillo D; Merlos M; Dickenson AH; Fernández-Pastor B; Cabañero D; Maldonado R
    Br J Pharmacol; 2019 Oct; 176(20):3939-3955. PubMed ID: 31332781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
    Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
    Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.
    Vidal-Torres A; de la Puente B; Rocasalbas M; Touriño C; Bura SA; Fernández-Pastor B; Romero L; Codony X; Zamanillo D; Buschmann H; Merlos M; Baeyens JM; Maldonado R; Vela JM
    Eur J Pharmacol; 2013 Jul; 711(1-3):63-72. PubMed ID: 23632394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia.
    Baamonde A; Lastra A; Juárez L; García V; Hidalgo A; Menéndez L
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):213-9. PubMed ID: 16283255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.
    Sauer RS; Hackel D; Morschel L; Sahlbach H; Wang Y; Mousa SA; Roewer N; Brack A; Rittner HL
    Mol Pain; 2014 Feb; 10():10. PubMed ID: 24499354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of peripheral μ-opioid analgesia by σ1 receptors.
    Sánchez-Fernández C; Montilla-García Á; González-Cano R; Nieto FR; Romero L; Artacho-Cordón A; Montes R; Fernández-Pastor B; Merlos M; Baeyens JM; Entrena JM; Cobos EJ
    J Pharmacol Exp Ther; 2014 Jan; 348(1):32-45. PubMed ID: 24155346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.
    Carlsson A; Ohsawa M; Hallberg M; Nyberg F; Kamei J
    Eur J Pharmacol; 2010 Jan; 626(2-3):250-5. PubMed ID: 19836387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats.
    Hagiwara S; Iwasaka H; Okuda K; Noguchi T
    Lasers Surg Med; 2007 Dec; 39(10):797-802. PubMed ID: 18081143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral opioids act as analgesics in bone cancer pain in mice.
    Menéndez L; Lastra A; Hidalgo A; Meana A; García E; Baamonde A
    Neuroreport; 2003 May; 14(6):867-9. PubMed ID: 12858049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation.
    Perrot S; Guilbaud G; Kayser V
    Anesthesiology; 2001 May; 94(5):870-5. PubMed ID: 11388540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal and peripheral mechanisms involved in the enhancement of morphine analgesia in acutely inflamed mice.
    González-Rodríguez S; Hidalgo A; Baamonde A; Menéndez L
    Cell Mol Neurobiol; 2010 Jan; 30(1):113-21. PubMed ID: 19655242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
    Ruiz-Cantero MC; González-Cano R; Tejada MÁ; Santos-Caballero M; Perazzoli G; Nieto FR; Cobos EJ
    Pharmacol Res; 2021 Jan; 163():105339. PubMed ID: 33276102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.
    Romero L; Merlos M; Vela JM
    Adv Pharmacol; 2016; 75():179-215. PubMed ID: 26920013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.